Abstract: Embodiments herein report compositions of and methods for making and using alpha-1 antitrypsin (AAT) fusion molecules or peptide derivatives thereof. In certain embodiments, compositions and methods relate to generating an AAT fusion molecule of use in pharmaceutically acceptable compositions to treat a subject in need of AAT therapy or treatment. In other embodiments, compositions and methods disclosed herein concern linking AAT or derivative thereof to an immune fragment.
Type:
Application
Filed:
October 10, 2019
Publication date:
July 16, 2020
Applicants:
The Regents of the University of Colorado, a Body Corporate, Konkuk University Industry Cooperation Foundation
Abstract: Embodiments herein report compositions of and methods for making and using alpha-1 antitrypsin (AAT) fusion molecules or peptide derivatives thereof. In certain embodiments, compositions and methods relate to generating an AAT fusion molecule of use in pharmaceutically acceptable compositions to treat a subject in need of AAT therapy or treatment. In other embodiments, compositions and methods disclosed herein concern linking AAT or derivative thereof to an immune fragment.
Type:
Grant
Filed:
January 10, 2013
Date of Patent:
November 19, 2019
Assignees:
The Regents of the University of Colorado, A Body Corporate, Konkuk University Industry Cooperation Foundation
Abstract: Embodiments herein report compositions of alpha-1 antitrypsin fusion polypeptides or peptide derivatives thereof. In certain embodiments, compositions and methods relate to generating a construct of use in pharmaceutically acceptable compositions to treat a subject in need of alpha-1 antitrypsin therapy or treatment. In other embodiments, compositions and methods disclosed herein concern linking alpha-1 antitrypsin or derivative thereof to an immune fragment.
Type:
Grant
Filed:
March 14, 2018
Date of Patent:
October 22, 2019
Assignees:
The Regents of the University of Colorado, Konkuk University Industry Cooperation Foundation
Abstract: Embodiments herein report compositions of and methods for making and using alpha-1 antitrypsin (AAT) fusion molecules or peptide derivatives thereof. In certain embodiments, compositions and methods relate to generating an AAT fusion molecule of use in pharmaceutically acceptable compositions to treat a subject in need of AAT therapy or treatment. In other embodiments, compositions and methods disclosed herein concern linking AAT or derivative thereof to an immune fragment.
Type:
Application
Filed:
April 30, 2018
Publication date:
September 6, 2018
Applicants:
The Regents of the University of Colorado, A Body Corporate, Konkuk University Industry Cooperation Foundation
Abstract: An arm-wrestling robot is disclosed, comprising basically an arm-force generation mechanism 10 and a control system 100 that detects the maximum arm-force of a user in the early stage of the match, generates a different game scenario each time, and executes force feedback control to implement the scenario.
Type:
Grant
Filed:
March 21, 2006
Date of Patent:
September 13, 2011
Assignee:
Konkuk University Industry Cooperation Foundation